Medication Management

• Diagnostic evaluation: Comprehensive assessment of symptoms, medical history, current medications, substance use, and relevant lab results to determine appropriate pharmacologic strategies.

• Medication selection and initiation: Evidence-based choice of psychotropic medications tailored to the diagnosis, symptom profile, comorbid medical conditions, age, pregnancy/breastfeeding status, and patient preferences.

• Dose titration and monitoring: Ongoing follow-up to adjust dosages for effectiveness and tolerability, monitor side effects, and manage drug interactions.

• Safety monitoring: Regular assessment for adverse effects, metabolic labs when indicated (e.g., lipids, glucose), weight checks, and suicide risk evaluation. Coordination with primary care for medical monitoring.

• Education and shared decision-making: Clear explanation of expected benefits, timelines, potential side effects, risks and alternatives to support informed consent.

• Long-term management and deprescribing: Periodic reassessment of need for continuation, strategies for tapering when appropriate, and relapse prevention planning.

Biopsychosocial Approach

• Integrated assessment: Evaluation that includes biological factors (genetics, neurobiology, medical illnesses), psychological factors (thought patterns, emotions, trauma history), and social factors (relationships, work, housing, cultural context).

• Coordinated care planning: Development of individualized treatment plans addressing medical, psychological, and social determinants of health; collaboration with primary care, specialists, social workers, and family as needed.

• Multimodal interventions: Combining pharmacologic treatment, psychotherapy, rehabilitation services, lifestyle interventions (sleep, nutrition, exercise), and social supports to target multiple contributors to mental health.

• Functional goals and rehabilitation: Focus on symptom reduction and restoring daily functioning—work, school, social participation—through skill-building, occupational support, and community resources.

• Culturally responsive care: Consideration of cultural, socioeconomic, and identity-related factors that influence presentation, treatment preferences, and access to services.

How these services work together

• Collaborative model: Clinicians integrate medication management, psychotherapy, and psychosocial interventions within a coordinated plan, sharing assessment findings and treatment goals.

• Personalized sequencing: Some patients start with psychotherapy alone, others with medication for symptom stabilization, and many receive concurrent treatments based on severity and preference. Personalized sequencing guides timing for tests, treatments, and sustainable lifestyle changes by combining individual data with behavior-focused coaching to optimize nutrition, stress, movement, and sleep.

What to expect at first visit

• Comprehensive intake, safety assessment, formulation of an initial treatment plan, discussion of options (medication, psychotherapy, combined), and scheduling of follow-up tailored to acuity and treatment choice.

We provide compassionate, evidence-based care for adults and adolescents experiencing a range of mental health and substance-related conditions, including:

• ADHD

• Depression

• Bipolar disorders

• Anxiety disorders

• Post-traumatic stress disorder (PTSD) and trauma-related conditions

• Obsessive-compulsive disorder (OCD)

• Schizophrenic spectrum disorders

• Substance use disorders (alcohol, stimulants, opioids, and other substances)

Treatment Services

• Comprehensive psychiatric evaluation and diagnosis

• Medication management tailored to each diagnosis and personal history

• Psychotherapy and coordinated referrals for evidence-based therapies (CBT, DBT, trauma-focused therapies, etc.)

• Integrated care plans that address co-occurring mental health and substance use conditions

• Care coordination with primary care, therapists, and community resources to support recovery and functioning

Medication-assisted treatment for opioid use disorder

We offer Medication-Assisted Treatment (MAT) for opioid use disorder, commonly known as Suboxone (buprenorphine/naloxone). MAT is provided as part of a comprehensive treatment plan that includes medical monitoring, counseling, and support for long-term recovery.

Medical cannabis certification

We provide evaluation and certification for medical marijuana cards where clinically appropriate and permitted by state law. Our clinicians assess eligibility based on current evidence and individual patient needs.

Approach and values

• Patient-centered: individualized treatment plans that respect each person’s goals and preferences

• Evidence-driven: use of current best practices in psychopharmacology and psychotherapy

• Integrated: collaboration across providers to treat the whole person, not just symptoms

• Respectful and stigma-free: care that honors dignity, supports recovery, and emphasizes safety

If you’re seeking evaluation or treatment for any of these conditions, we can help you get started with an initial assessment and a clear, personalized plan of care.